Franklin R Schneier
Overview
Explore the profile of Franklin R Schneier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
1524
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Ginat-Frolich R, Gilboa-Schechtman E, Huppert J, Aderka I, Alden L, Bar-Haim Y, et al.
Clin Psychol Rev
. 2024 Mar;
109:102415.
PMID: 38493675
What are the major vulnerabilities in people with social anxiety? What are the most promising directions for translational research pertaining to this condition? The present paper provides an integrative summary...
3.
Schneier F, Feusner J, Wheaton M, Gomez G, Cornejo G, Naraindas A, et al.
J Psychiatr Res
. 2023 Apr;
161:364-370.
PMID: 37004409
Objective: Body dysmorphic disorder (BDD) is an often-severe condition in which individuals are preoccupied by misperceptions of their appearance as defective or ugly. Only serotonin reuptake inhibitors and cognitive-behavioral therapy...
4.
Groenewold N, Bas-Hoogendam J, Amod A, Laansma M, van Velzen L, Aghajani M, et al.
Mol Psychiatry
. 2023 Jan;
28(3):1079-1089.
PMID: 36653677
There is limited convergence in neuroimaging investigations into volumes of subcortical brain regions in social anxiety disorder (SAD). The inconsistent findings may arise from variations in methodological approaches across studies,...
5.
Massad R, Hertz-Palmor N, Schneier F, Lazarov A
J Anxiety Disord
. 2022 Jun;
89:102589.
PMID: 35689849
Accurate assessment is crucial for determining appropriate therapeutic interventions for social anxiety and conducting sound clinical research. While self-report measures of social anxiety are widely used in both research and...
6.
Dillon D, Lazarov A, Dolan S, Bar-Haim Y, Pizzagalli D, Schneier F
Emotion
. 2021 Dec;
22(1):1-18.
PMID: 34968142
Choices and response times in two-alternative decision-making tasks can be modeled by assuming that individuals steadily accrue evidence in favor of each alternative until a response boundary for one of...
7.
Reinen J, Whitton A, Pizzagalli D, Slifstein M, Abi-Dargham A, McGrath P, et al.
Eur Neuropsychopharmacol
. 2021 Sep;
53:89-100.
PMID: 34517334
Major depressive disorder (MDD) is characterized by behavioral and neural abnormalities in processing both rewarding and aversive stimuli, which may impact motivational and affective symptoms. Learning paradigms have been used...
8.
Lazarov A, Basel D, Dolan S, Dillon D, Pizzagalli D, Schneier F
J Affect Disord
. 2021 May;
290:169-177.
PMID: 34000570
Background: Threat-related attention bias has been implicated in the etiology and maintenance of social anxiety disorder (SAD), with attentional research increasingly using eye-tracking methodology to overcome the poor psychometric properties...
9.
Fyer A, Schneier F, Simpson H, Choo T, Tacopina S, Kimeldorf M, et al.
J Affect Disord
. 2020 Aug;
275:329-338.
PMID: 32734926
Background: To assess within and across diagnosis variability we examined fear processing in healthy controls (HC) and three diagnostic groups that share symptoms of pathological anxiety: obsessive compulsive disorder (OCD);...
10.
Whitton A, Reinen J, Slifstein M, Ang Y, McGrath P, Iosifescu D, et al.
Brain
. 2020 Feb;
143(2):701-710.
PMID: 32040562
The efficacy of dopamine agonists in treating major depressive disorder has been hypothesized to stem from effects on ventrostriatal dopamine and reward function. However, an important question is whether dopamine...